Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PHGDH-inactive

Copy Product Info
🥰Excellent
Catalog No. T23150Cas No. 1914971-16-6

PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 [1].

PHGDH-inactive

PHGDH-inactive

Copy Product Info
🥰Excellent
Purity: 99.83%
Catalog No. T23150Cas No. 1914971-16-6
PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 [1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$32In StockIn Stock
10 mg$55In StockIn Stock
25 mg$119In StockIn Stock
50 mg$191In StockIn Stock
100 mg$275In StockIn Stock
200 mg$386In StockIn Stock
1 mL x 10 mM (in DMSO)$39In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.83%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PHGDH-inactive AI Summary
PHGDH-inactive exhibits bioactivity as an inhibitor of 15-hydroxyprostaglandin dehydrogenase (HPGD) and demonstrates a potency of 30401.6 nM against ALDH1A1 (Aldehyde dehydrogenase 1 family member A1) according to PubChem BioAssay data. Additionally, it shows inhibitory effects on human liver N-terminal His6-tagged PHGDH enzyme expressed in Escherichia coli Rosetta (DE3)pLysS, with an IC50 value greater than 57000.0 nM, indicating moderate to weak inhibition. In specific assays, PHGDH-inactive has an inhibitory effect of 33.0% against PHGDH and exhibits high kinetic solubility in pH 7.4 buffer and aqueous solubility. Furthermore, the compound has a half-life of more than 0.5 hours in rat liver microsomes, suggesting potential stability in this biological environment..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 [1].
Chemical Properties
Molecular Weight327.45
FormulaC17H21N5S
Cas No.1914971-16-6
SmilesCc1cc(C)nc(NC(=S)N2CCN(CC2)c2ccncc2)c1
Relative Density.1.268 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 8 mg/mL (24.43 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (3.05 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0539 mL15.2695 mL30.5390 mL152.6951 mL
5 mM0.6108 mL3.0539 mL6.1078 mL30.5390 mL
10 mM0.3054 mL1.5270 mL3.0539 mL15.2695 mL
20 mM0.1527 mL0.7635 mL1.5270 mL7.6348 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PHGDH-inactive | purchase PHGDH-inactive | PHGDH-inactive cost | order PHGDH-inactive | PHGDH-inactive chemical structure | PHGDH-inactive formula | PHGDH-inactive molecular weight